| Patient | Jackie Robinson |
|---|---|
| Date of birth | 1974-01-31 |
| Identifiers | MRN HR-ML037-SYN; SSN (made up) 000-37-2286 |
| Document date | 2026-07-29 |
| Author | Priya Ostrowski-Lane, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Blurred vision in both eyes for two months and new floaters in the right eye for four days in a 52-year-old man with type 2 diabetes for about fifteen years and an A1c of 10.4%. Snellen acuity 20/200 right and 20/80 left; the undilated view of the right fundus is poor. Please examine for proliferative retinopathy, vitreous hemorrhage, retinal detachment and macular edema, and treat as needed. [S]
Urgency: Within 48 hours, by phone arrangement today; same-day attendance if a curtain over the vision or flashes appear. [S]
Questions for the consultant:
Mr. Robinson, 52, is seen at the request of Dr. Delacroix-Hale two days after he reported two months of blurred vision in both eyes and new floaters in the right eye. He has had no flashes, no curtain over his vision and no eye pain. He has had diabetes for about fifteen years, with high blood pressure, peripheral artery disease and two mild strokes a year ago, and his last dilated eye examination was more than two years ago. He takes aspirin. He is grieving the recent death of his son and is frightened of losing his sight. He agreed to examination with dilating drops, ultrasound and OCT, and, after the risks of infection, raised eye pressure and bleeding were explained, to injections today. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
6 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin 1,000 mg oral tablet, one tablet twice daily with meals | One tablet twice daily with meals | Oral route | 2025-03-03 | active | S |
| Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70 | At bedtime, by the gradual titration plan | Subcutaneous route | 2025-03-03 | active | S |
| Lisinopril 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2025-03-03 to 2026-07-29 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake) | One tablet daily | Oral route | 2026-07-27 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 2025-03-03 | active | S |
| Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutes | As needed for severe low blood sugar | Nasal route | 2026-07-27 | active | S |
| Lisinopril 40 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating | One tablet daily, with sick-day rules | Oral route | 2026-07-29 | active | S |
| Empagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating, and before surgery or a colonoscopy preparation | One tablet daily, with sick-day rules | Oral route | 2026-07-29 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arranged | resolved | confirmed | H53.8 | S — Synthetic presenting finding, superseded by the retinal diagnosis two days later. |
| Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arranged | active | confirmed | R07.89 | S — Synthetic presenting finding, superseded by the coronary diagnosis after the stress test. |
| Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%) | active | confirmed | E11.65 | S — Synthetic modern episode linked to his documented diabetes. |
| Proliferative diabetic retinopathy in both eyes with center-involving diabetic macular edema (central subfield 412 microns right, 468 left); best-corrected acuity 35 letters right and 56 letters left | active | confirmed | E11.3513 | S — Synthetic retinal findings anchored to his documented loss of vision. |
| Vitreous hemorrhage in the right eye from proliferative retinopathy; retina attached on ultrasound | active | confirmed | H43.11 | S — Synthetic finding. |
| Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg) | active | confirmed | I12.9 | S — Synthetic modern episode linked to his documented high blood pressure. |
| Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79 | active | confirmed | E11.22 | S — Synthetic kidney findings. |
| Chronic kidney disease G2 A2 | active | confirmed | N18.2 | S — Synthetic kidney finding. |
| Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulses | active | confirmed | E11.51 | S — Synthetic modern episode linked to the documented artery damage in his legs. |
| Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testing | active | confirmed | E11.42 | S — Synthetic modern episode linked to the documented nerve damage in his legs. |
| History of two mild strokes a year ago, without lasting weakness | active | confirmed | Z86.73 | S — Synthetic modern coding of the documented strokes. |
| Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dL | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
| Bereavement: his eldest son died in a car crash six weeks ago | active | confirmed | Z63.4 | S — Synthetic modern coding of a documented loss; grief is treated as grief, not as a disorder. |
Vital signs recorded on 2026-07-29; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| Visual acuity | Best-corrected 35 letters right and 56 letters left |
| Anterior segment | Clear corneas; mild early lens opacity in both eyes; no new vessels on the iris or in the angle on gonioscopy |
| Right fundus (dilated) | Dense inferior vitreous hemorrhage; neovascularization of the disc seen superiorly; macular thickening with exudates where visible |
| Left fundus (dilated) | Neovascularization of the disc and elsewhere; intraretinal hemorrhages in four quadrants; hard exudates and thickening at the center of the macula |
| Vital signs | Blood pressure 148/90 and pulse 82, measured today |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-29 | Visual acuity best corrected Right eye by ETDRS eye chart | 35 | {letters} | 85 letters is about 20/20; 35 letters is about 20/200 | Low | S |
| 2026-07-29 | Visual acuity best corrected Left eye by ETDRS eye chart | 56 | {letters} | 85 letters is about 20/20; 55 letters is about 20/80 | Low | S |
| 2026-07-29 | Macular grid.center subfield thickness by OCT | 412 | um | 200-300 um | High | S |
| 2026-07-29 | Macular grid.center subfield thickness by OCT | 468 | um | 200-300 um | High | S |
Data reviewed: Dr. Delacroix-Hale's note and results: A1c 10.4%; blood pressure 152/92; eGFR 79; urine albumin-to-creatinine ratio 86 mg/g; LDL 142 mg/dL. Today: best-corrected acuity 35 letters right and 56 letters left (about 20/200 and 20/80). Intraocular pressure 16 mmHg right and 15 left. OCT: center-involving macular edema, central subfield 412 microns right and 468 left, with intraretinal fluid in both eyes. B-scan ultrasound of the right eye: vitreous hemorrhage, retina attached, no tractional detachment. [S]